Introduction to the Generic Drug Supply Chain | Association for Accessible Medicines
AAM All Access Podcast - Featuring AAM CEO Dan Leonard and leaders in the generics and biosimilars industry.

Introduction to the Generic Drug Supply Chain

It is important that policymakers consider the differences inherent in the branded and generic prescription drug markets when considering public policy changes concerning drug pricing. The differences between the respective markets may require solutions tailored to the specific challenges, rather than a one-size-fits-all solution. In doing so, policymakers should carefully consider how to ensure the sustainability of generic drug markets and a stable supply of lifesaving generic medicines.

Learn more about the important differences between the brand name and generic prescription supply chains.

Read Brief

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.